Smecta package 3g №10 vanilla

Tradename: Smecta®
International non-proprietary name or grouping name: Dioctahedral smectite

Dosage Form: Powder for the preparation of suspensions for oral administration [orange, vanilla].

The composition of the drug for 1 sachet.

Active substances: Dioctahedral smectite 3 g

Excipients: powder for suspension for oral administration [orange]: orange flavoring 0.010 g; vanilla flavoring 0.050 g; dextrose monohydrate 0.679 g; sodium saccharinate 0.021 g; powder for suspension for oral administration [vanilla]: vanillin 0.004 g; dextrose monohydrate 0.749 g; sodium saccharinate 0,007 g

Description Powder from grayish-white to light grayish-yellow color with a smell from a weak non-specific to a weak vanilla. Pharmacotherapeutic group antidiarrhoeal

pharmachologic effect The drug is an aluminosilicate of natural origin, has an adsorbing effect. It stabilizes the mucous barrier of the gastrointestinal tract, forms polyvalent bonds with mucus glycoproteins, increases its quantity, improves cytoprotective properties (in relation to the negative effect of hydrochloric acid, bile salts, microorganisms and their toxins).It has selective sorption properties, which are explained by its discoid-crystal structure; adsorbs bacteria and viruses in the lumen of the gastrointestinal tract. In therapeutic doses, does not affect intestinal motility. Diosmectite is radiolucent and does not stain stools. Aluminum in the composition of smectite is not absorbed from the gastrointestinal tract, including in diseases of the gastrointestinal tract, accompanied by symptoms of colitis and colonopathy.

Indications for use In children (including infants) and adults: Acute and chronic diarrhea (allergic, medicinal genesis; violation of the diet and qualitative composition of food), diarrhea of ​​infectious genesis - as part of complex therapy. Symptomatic treatment of heartburn, bloating, abdominal discomfort and other symptoms of dyspepsia accompanying diseases of the gastrointestinal tract.

Contraindications Hypersensitivity, intestinal obstruction, fructose intolerance, glucose-galactose malabsorption, sucrose-isomaltase deficiency.

Dosage and administration

Use in acute diarrhea.

Children, including babies:

Up to 1 year: 2 sachets per day for 3 days, then - 1 sachet per day;

Older than 1 year: 4 sachets per day for 3 days, then 2 sachets per day.

Adults:

The recommended dosing regimen is 6 sachets per day.

Application for other indications. Children, including babies:

up to 1 year: 1 sachet per day;

1-2 years: 1-2 sachets per day;

older than 2 years: 2-3 sachets per day.

Adults:

3 sachets per day.

A treatment course of 3-7 days is recommended. When esophagitis Smektu should be taken orally after a meal, with other indications - between meals. For children, the contents of the bags are dissolved in a baby bottle (50 ml) and distributed into several doses throughout the day or mixed with some semi-liquid product (cereal, mashed potatoes, compote, baby food). For adults, the contents of the bags are dissolved in ½ cup of water, gradually pouring the powder and stirring it evenly. The prescribed dose is divided into 3 doses throughout the day.

Warnings and Precautions It is recommended to observe the interval of 1-2 hours between taking Smecta and other medicines. Use with caution in patients with severe chronic constipation in history. In children with acute diarrhea, the drug should be used in conjunction with measures for rehydration. If necessary, adults can also be prescribed drug therapy in combination with rehydration measures. The complex of measures for rehydration is assigned depending on the course of the disease, the age and characteristics of the patient.

Overdose Overdose can cause severe constipation or bezoar.

Side effect In clinical studies, rare cases of constipation have been reported. In all cases, this phenomenon was mild and disappeared after an individual change in the dosing regimen. In routine practice, in very rare cases, hypersensitivity reactions have been reported, incl. urticaria, rash, itching or angioedema. Interaction with other drugs The drug can reduce the rate and extent of absorption of simultaneously taken drugs. It is not recommended to take Smecta along with other drugs. Use during pregnancy and during breastfeeding Smecta is approved for use in pregnant and lactating women. Correction of dosage and regimen is not required.

Impact on driving vehicles and driving mechanisms No information available.

Release form Powder for the preparation of suspensions for oral administration [orange, vanilla], 3 g. 3.76 g of the drug is placed in sachets of paper, laminated with aluminum foil and polyethylene. 10 or 30 sachets with instructions placed in a cardboard box.

Shelf life 3 years. Do not use after the expiration date printed on the package.

Storage conditions Store at a temperature not higher than 25º С, out of the reach of children.

Over the counter